Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

News & Events

2012 News
 

1/26/12
Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia

 

 

 

News Links:
2012
2011
2010
2009
2008
2007
2006
2005
Upcoming Events

 

 

 



 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.